Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
131i-tm-601 (6 trials)
Adenocarcinoma (Phase 1)
Astrocytoma (Phase 2)
Brain Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Gliosarcoma (Phase 2)
Melanoma (Phase 2)
Oligodendroglioma (Phase 2)
Trials (6 total)
Trial APIs (1 total)